Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/18/1997 | US5688912 Peptide ligands which bind to von willebrand factor |
11/18/1997 | US5688911 Tyrosine kinase receptors |
11/18/1997 | US5688768 Recombinant thrombin receptor and related pharmaceuticals |
11/18/1997 | US5688767 Treatment of endotoxin-associated disorders with cationic peptides |
11/18/1997 | US5688766 Cystatin proteins |
11/18/1997 | US5688764 Insecticidal peptides from spider venom |
11/18/1997 | US5688763 Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein |
11/18/1997 | US5688762 Method of treating hypertension using animal stomach mucosa extract and endogenous protease-inhibitor peptides |
11/18/1997 | US5688760 Polypeptides having bone resorption inhibitory activity comprising PTHrP-derived sequences |
11/18/1997 | US5688691 Insect retinoid-like receptor compositions and methods |
11/18/1997 | US5688690 Human cytotoxic lymphocyte signal transduction surface protein (P38) and monoclonal antibodies thereto |
11/18/1997 | US5688688 Vector for expression of a polypeptide in a mammalian cell |
11/18/1997 | US5688679 Human erythropoietin gene; high level expression in stably transfected mammalian cells |
11/18/1997 | US5688678 Induce bone formation; wound healing agents |
11/18/1997 | US5688677 Administering dna for treatment of cystic fibrosis with transmembrane conductance controllers |
11/18/1997 | US5688669 Methods for nucleic acid detection, sequencing, and cloning using exonuclease |
11/18/1997 | US5688666 Growth hormone variants with altered binding properties |
11/18/1997 | US5688665 Binding to cyclin dependent kinases; controlling cell reproduction |
11/18/1997 | US5688662 Gustducin polynucleotides, vectors, host cells and recombinant methods |
11/18/1997 | US5688659 Incubation of sample peptide antigen to form antigen-antibody complex detection of antibodies |
11/18/1997 | US5688657 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor |
11/18/1997 | US5688656 Cytokine-induced marker for inflammatory response |
11/18/1997 | US5688652 Detection of collagen degradation in vivo |
11/18/1997 | US5688641 Breast cancer |
11/18/1997 | US5688637 Kits for detection of aids, amplification of strands of nucleic acid and hybridization in the presence of polymerases |
11/18/1997 | US5688513 Immunology with polypeptides against eimeria and coccidiosis |
11/18/1997 | US5688512 Vaccines |
11/18/1997 | US5688511 Cellular protein TDP-43 and regulation of HIV-1 gene expression |
11/18/1997 | US5688507 Cardiovascular disorders such as treatment of angina, heart attack, stroke and as anticoagulants |
11/18/1997 | US5688505 Method for treating cancer with monoclonal antibodies to oncofetal protein |
11/18/1997 | US5688501 Treating infectious disease caused by bacteria by administering bacteriophages obtained by serial passage through circulatory system and selected to have longer half-life |
11/18/1997 | US5688489 Non-receptor mediated imaging agents |
11/18/1997 | CA1339544C Novel glucose isomerase enzymes and their use |
11/17/1997 | CA2205074A1 Recombinant vectors |
11/13/1997 | WO1997042504A1 Immunoassay of total insulin-like growth factor binding protein-1 |
11/13/1997 | WO1997042343A2 Teichoic acid enzymes and assays |
11/13/1997 | WO1997042340A1 Ob receptor isoforms and nucleic acids encoding them |
11/13/1997 | WO1997042337A1 Gene expression in monocytes and macrophages |
11/13/1997 | WO1997042335A1 Polycistronic expression plasmid for tumor-rejection |
11/13/1997 | WO1997042333A1 Methods and compositions for production of plant foodstuffs with enhanced sweet component of flavor |
11/13/1997 | WO1997042330A1 Chain reaction cloning |
11/13/1997 | WO1997042329A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
11/13/1997 | WO1997042325A1 B. burgdorferi polypeptides expressed in vivo |
11/13/1997 | WO1997042323A1 Treatment of human cancers with an adenovirus vector containing an interferon consensus gene |
11/13/1997 | WO1997042322A1 Glycoprotein hormone superagonists |
11/13/1997 | WO1997042321A1 Osteoclast transporter protein |
11/13/1997 | WO1997042320A1 Mutant aequorea victoria fluorescent proteins having increased cellular fluorescence |
11/13/1997 | WO1997042319A1 NOVEL Fas ANTIGEN DERIVATIVES |
11/13/1997 | WO1997042318A1 Vaccines |
11/13/1997 | WO1997042316A1 Transgenic plants resistant to geminivirus infection |
11/13/1997 | WO1997042315A1 Transgenic plants resistant to geminivirus infection |
11/13/1997 | WO1997042314A1 Nucleic acid encoding spinocerebellar ataxia-2 and products related thereto |
11/13/1997 | WO1997042312A1 Transgenic mammals capable of expressing leukemia inhibitory factor |
11/13/1997 | WO1997042309A1 TRANSGENIC ANIMALS DEFICIENT IN ENDOGENOUS β3-ADRENERGIC RECEPTOR AND USES THEREOF |
11/13/1997 | WO1997042224A1 Neurotactin and uses therefor |
11/13/1997 | WO1997042223A1 hGH-RH(1-29)NH2 ANALOGUES HAVING ANTAGONISTIC ACTIVITY |
11/13/1997 | WO1997042222A1 Methods and means for inhibition of cdk4 activity |
11/13/1997 | WO1997042221A1 Novel osp-c derived peptide fragments |
11/13/1997 | WO1997042220A1 Metastatic colorectal cancer vaccine |
11/13/1997 | WO1997042219A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS A TUMOR SUPPRESSOR |
11/13/1997 | WO1997042218A1 MAMMALIAN SEX COMB ON MIDLEG (MAMMALIAN Scm) ACTS AS AN ONCOGENE |
11/13/1997 | WO1997042217A1 Radiolabeled fusion toxins for cancer therapy |
11/13/1997 | WO1997042213A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE |
11/13/1997 | WO1997042211A1 Mammalian sex comb on midleg (mammalian scm) acts as a tumor suppressor |
11/13/1997 | WO1997042210A1 Identification of essential survival genes |
11/13/1997 | WO1997042209A1 Human rad |
11/13/1997 | WO1997041895A2 TREATMENT OF ASTHMA WITH TNFR-Ig |
11/13/1997 | WO1997041892A1 Chimeric kanamycin resistance gene |
11/13/1997 | WO1997041887A1 Treatment of partial growth hormone insensitivity syndrome |
11/13/1997 | WO1997041884A1 Method of treatment |
11/13/1997 | WO1997041881A1 Morphogen treatment for chronic renal failure |
11/13/1997 | WO1997041880A1 Therapies for chronic renal failure |
11/13/1997 | WO1997041824A2 Antiangiogenic peptides derived from plasminogen |
11/13/1997 | WO1997041823A2 MOLECULAR GENETIC CONSTRUCTION OF VACCINE STRAINS OF $i(PASTEURELLACEAE) |
11/13/1997 | WO1997041731A1 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
11/13/1997 | WO1997037998A3 Neuropeptide y receptor y5 and nucleic acid sequence |
11/13/1997 | WO1997033996A3 Human bikunin |
11/13/1997 | WO1997032607A3 Activated linkers and methods for making and purifying the same |
11/13/1997 | WO1997032020A3 Shc proteins |
11/13/1997 | WO1997029195A3 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
11/13/1997 | CA2253971A1 Use of high dose interferon by oralmucosal contact to treat viral infections and neoplastic conditions |
11/13/1997 | CA2253880A1 Chain reaction cloning |
11/13/1997 | CA2253864A1 Neurotactin and uses therefor |
11/13/1997 | CA2253834A1 B. burgdorferi polypeptides expressed in vivo |
11/13/1997 | CA2253832A1 Ob receptor isoforms and nucleic acids encoding them |
11/13/1997 | CA2253600A1 Identification of essential survival genes |
11/13/1997 | CA2253557A1 Treatment of asthma with tnfr-ig |
11/13/1997 | CA2253494A1 Novel fas antigen derivative |
11/13/1997 | CA2253441A1 Glycoprotein hormone superagonists |
11/13/1997 | CA2253328A1 Polycistronic expression plasmid for tumor-rejection |
11/13/1997 | CA2253322A1 Gene expression in monocytes and macrophages |
11/13/1997 | CA2252845A1 Chimeric kanamycin resistance gene |
11/13/1997 | CA2252470A1 Treatment of human cancers with an adenovirus vector containing an interferon consensus gene |
11/13/1997 | CA2250579A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
11/12/1997 | EP0806670A2 Use of an anticoagulant as a diagnostic agent |
11/12/1997 | EP0806669A2 Diagnostic reagent for hepatitis c virus infection |
11/12/1997 | EP0806484A2 Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of these viral genomes and to the in vitro diagnosis of infections resulting from these viruses |
11/12/1997 | EP0806480A2 Frenolicin gene cluster |
11/12/1997 | EP0806478A2 p53as Protein and antibody therefor |
11/12/1997 | EP0806477A1 Recombinant dna prepared by integrating dna that codes for myosin heavy-chain sm1 isoform protein into vector dna, and microorganism and arteriosclerosis remedy both containing the recombinant dna |